The MD Learning Channel is a free, one-stop shop for clinical education resources.
Release Date: March 28, 2016 Expiration Date: March 27, 2019
Target Audience: Surgeons and primary care physicians Disclosure: Dr. Chen has no financial relationships related to the content of this activity to disclose. There is no commercial support for this activity.
Learning Objective / Overview: UAB Medicine Surgeon-in-Chief Herbert Chen, MD, discusses hyperparathyroidism (HPT), which affects roughly 1 percent of the U.S. population and is more common in women and the elderly. It is the third most common endocrine disorder after diabetes and thyroid disease. Marked by an abnormally high concentration of parathyroid hormone in the blood, HPT results in a loss of calcium and weakened bones. The only curative option is surgery, a minimally invasive procedure called radio-guided parathyroidectomy, which offers numerous quality-of-life benefits for patients, a short recovery time, and very little risk. Dr. Chen has performed nearly 2,000 such procedures at UAB and recommends that all patients with HPT be referred for a surgical consult.
Accreditation statement:The University of Alabama School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. The University of Alabama School of Medicine designates this online enduring material activity for a maximum of 0.5 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
In part one of his grand rounds lecture, Carlo M. Contreras, MD, FACS, discusses how the adequacy of lymphadenectomy has been defined in other gastrointestinal epithelial cancer and how we might apply that to pancreatic cancer through the use of the American College of Surgeons national database.
In part two of his grand rounds lecture, Carlo M. Contreras, MD, FACS, discusses chemotherapy options, the role of surgical lymphatic staging, and estimating prognosis of melanoma.
Courtney Balentine, MD, MPH, assistant professor in the UAB Department of Surgery, discusses differences in utilization of skilled nursing facilities, rehabilitation, and home health care after surgery, and how this affects patient outcomes.
Martin J. Heslin, MD, discusses diagnosis and proper management of neoplastic pancreatic cysts.
The Current Role of Sentinel Lymph Node Biopsy in Melanoma
Marshall Urist, MD, discusses the current role of sentinel lymph node biopsy in melanoma.
Chemotherapy for Pancreatic Cancer
John D. Christein, MD, discusses the history of adjuvant therapy for pancreatic cancer, rationalizes the arguments for both pre- and post-operative therapy, and conceptualizes borderline resectable pancreatic cancer.
Lymph Node Dissection for Well-Differentiated Thyroid Cancer
Thomas N. Wang, MD, PhD, discusses where it is necessary to dissect the lymph node for well-differentiated thyroid cancer.
Alabama Trauma System Update
Patrick Bosarge, MD, discusses the Alabama Trauma System (ATS) and what that means for patients and referring physicians.
Pancreatitis: When to disturb the beast?
John D. Christein, MD, discusses the basic treatment for necrotizing pancreatitis, the non-operative and pre-operative principles, and to whom and when to operate.
Pre-operative Optimization for Ventral Hernia RepairPeace
Britney Corey, MD, discusses the pre-operative optimization of certain risk factors for ventral hernia repairs.
The Future of Minimally Invasive General Surgery
John Porterfield, MD, discusses the training curriculum of minimally invasive surgery and what the next generation of surgeon look like.
Paradigms in Blood Utilization
Jeffery D. Kerby, MD, discusses how UAB Medicine has adjusted its protocols to gain better results with blood management in trauma care.
Breast Cancer Surgical Margins Update
Through a series of case studies, Rachael B. Lancaster, MD, gives an update on breast cancer surgical margins and discusses the recent changes in the landscape.
Diverse Applications of Intraoperative PTH Testing?
Herbert Chen, MD, FACS, discusses the benefits of having rapid parathyroid testing in your operating room.
Enterocutaneous Fistulas: What do we do?
Lauren Tanner, MD, discusses diagnosis and the goals of management for enterocutaneous fistulas.
Familial & Hereditary Colorectal Cancers
Daniel I. Chu, MD, discusses hereditary colorectal cancers and when you should consider referring your patient for genetic testings.
Indications for Neoadjuvant Therapy in Breast Cancer Therapy
Rachael B. Lancaster, MD, discusses the indications and prognosis for neoadjuvant therapy in breast cancer and illustrates these points with case studies.
Diverticulitis: To Operate or Not?
Melanie Morris, MD, discusses the epidemiology, evaluation, and treatment of acute non-complicated diverticulitis and complicated diverticulitis.
When to refer a breast cancer patient to genetic testing?
Helen Krontiras, MD, discusses types of breast cancers and when it is appropriate to refer a breast cancer patient to genetic testing.
Optimal Preoperative Evaluation in the Esophageal Cancer Patient
Benjamin Wei, MD, discusses the optimal preoperative evaluation of patients with esophageal cancer, which includes staging the cancer, evaluating the patient, and determining the optimal therapy.
Neoadjuvant Chemotherapy for Gastric Cancer Patients
Carlo M. Contreras, MD, FACS, discusses the benefits of several neoadjuvant treatment options for patients with gastric cancer.
Laparoscopy in Colorectal Cancer
Gregory D. Kennedy, MD, gives an update on surgical therapies for colorectal cancer and discusses neoadjuvant and adjuvant chemotherapy options.
Controversies in Timing of Operative Management of Bowel Obstruction
Virginia Strickland, MD, discusses the operative indications for small bowel obstruction.
Initial Burn Management
Major Justin Manley, USAF, MC, discusses the initial assessment, acute resuscitation, transfer criteria, special considerations, and wound care of burn patients.
Gregory Kennedy, MD, PhD, director of GI surgery, discusses logical algorithms to diagnoses and treat benign anorectal diseases such as hemorrhoids, fissure-in-ano, cryptoglandular disease, and pilonidal disease.
Inflammatory Bowel Disease & Surgical Disparities
Daniel I. Chu, MD, assistant professor in the department of general surgery, division of gastrointestinal surgery, discusses the difficulties in management of inflammatory bowel disease (IBD), specifically for African-American patients, and surgical disparities and outcomes related to the disease.
Post-Operative 30-day Readmission
Melanie Morris, MD, associate professor of surgery in the Division of GI Surgery at UAB Medicine, discusses her study aimed at understanding the relative contributions of unplanned 30-day post-operative readmissions.
Improving Outcomes in Colorectal Cancer
Greg Kennedy, Ph.D., M.D., an internationally recognized surgeon and researcher, discusses the continuum of research on improving outcomes of colorectal cancer.
Visiting UCSF professor, M. Margaret Knudson, MD, FACS, discusses advancements in technology and best practices in trauma surgery, including better collaboration between military and civilian trauma surgeons.
Visiting University of Wisconsin professor, Caprice Christian Greenberg, MD, MPH, discusses the challenges in overcoming learning gaps among surgeons. She highlights the advantages of video-based coaching over real-time instruction, as well as self-assessment tools.
Visiting University of Iowa professor, Ronald J. Weigel, MD, PhD, MBA, discusses advances in breast cancer treatment, including how the biology of specific breast cancers affect patient care, specifically, how patterns of gene expression can predict life expectancy, and the impact of neoadjuvant therapy on outcomes.